Grail, Inc. (NASDAQ:GRAL) Short Interest Update

Grail, Inc. (NASDAQ:GRAL) was the target of a large increase in short interest in the month of July. As of July 31st, there was short interest totalling 3,390,000 shares, an increase of 9.4% from the July 15th total of 3,100,000 shares. Approximately 12.8% of the company’s shares are short sold. Based on an average trading volume of 1,670,000 shares, the short-interest ratio is currently 2.0 days.

Grail Price Performance

Shares of GRAL traded down $0.57 during mid-day trading on Monday, hitting $16.18. The company had a trading volume of 439,091 shares, compared to its average volume of 1,559,489. Grail has a 1-year low of $12.51 and a 1-year high of $23.36.

Grail Company Profile

GRAIL, LLC, a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer.